Accessibility Statement

The Cancer Research Institute is committed to making its website usable by all people, including those with disabilities by meeting or exceeding the requirements of the Web Content Accessibility Guidelines 2.1 Level A/AA (WCAG 2.1 A/AA). We strive in making our site an equal playing field for everyone.

We continue to monitor our site and make sure that all content provided is accessible to all visitors. In order to help us in this process, we have engaged The Bureau of Internet Accessibility (BoIA.org), an accessibility consulting company, to conduct a full accessibility audit consisting of both automated and manual testing of our website using BoIA’s A11Y® platform which provides us with specific recommendations that will assist us in ensuring that our Web presence is in conformance with the WCAG 2.1 A/AA.

Disclaimer

It is important to note that efforts to the website are ongoing as we work to implement the relevant improvements to meet WCAG 2.1 A/AA guidelines over time.

OUR COMMITMENT TO HELP

We are dedicated to meeting all of your accessibility needs. Should you have specific questions or concerns about the accessibility of this site or need assistance in using the processes found within this site, we have trained individuals here at the Cancer Research Institute to assist you.

Please contact us directly at (800) 992-2623 or [email protected]. We would be happy to assist in making your visits to our site as convenient as possible.

THIRD PARTY APPLICATIONS

While you are visiting our site, you will notice that we make use of third-party sites such as Facebook, Twitter, YouTube, LinkedIn, and Instagram to provide information about the Cancer Research Institute. Though individuals may have challenges with access to these particular sites, the Cancer Research Institute does not control or remedy the way content is portrayed.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.